🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Min-Tze LIONG clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Min-Tze LIONG as lead sponsor. Synced 26 Sep 2026
6Current trials
2Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Min-Tze LIONG is the lead sponsor of 6 current clinical trials in our China register. 2 are recruiting patients now. The most common phase is Phase 2. The most-studied condition is Recurrent Respiratory Tract Infections.

ClinicalTrials.gov trials by status

  • Recruiting233%
  • Not yet open233%
  • Active, closed117%
  • By invitation117%

Trials by phase

  • Phase 2583%
  • Observational117%
01

Clinical trials sponsored by Min-Tze LIONG

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
NCT07297966 · ClinicalTrials.gov ↗ · Recurrent Respiratory Tract Infections
Phase 2 Recruiting 2025-05 China
To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants
NCT07490587 · ClinicalTrials.gov ↗ · Healthy Children
Phase 2 Recruiting 2024-01 China
Integrated Study on Gut Microbiota, Immune Indicators, and Trace Elements in Children With Respiratory Tract Infections
NCT07378852 · ClinicalTrials.gov ↗ · Respiratory
Observational Not yet open 2026-01 China
The Effect of Probiotics on Gut Microbiota Changes in Healthy Chinese Adults During Short-Term European Travel: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial
NCT07384260 · ClinicalTrials.gov ↗ · Healthy Adult
Phase 2 Not yet open 2026-02 China
Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study
NCT07498127 · ClinicalTrials.gov ↗ · URTI
Phase 2 By invitation 2026-02 China
Study on the Efficacy of Probiotics in the Treatment of Childhood Obesity and Their Effects on Gut Microbiota
NCT07448220 · ClinicalTrials.gov ↗ · Overweight , Obesity
Phase 2 Active, closed 2023-12 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Min-Tze LIONG trials

6 conditions
Recurrent Respiratory Tract Infections1Healthy Children1Respiratory1Overweight , Obesity1Healthy Adult1URTI1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in China62

A trial with sites in more than one country appears in each of those registers.

04

Questions about Min-Tze LIONG trials

How many clinical trials does Min-Tze LIONG sponsor?

Min-Tze LIONG is the lead sponsor of 6 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Min-Tze LIONG trials recruiting?

Yes. 2 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.